LncRNA MALAT1 Increases the Stemness of Gastric Cancer Cells Via Enhancing SOX2 MRNA Stability

Overview

Journal FEBS Open Bio

Specialty Biology

Date 2019 May 1

PMID 31037832

Citations 41

Authors

Yiwen Xiao

Jingjing Pan

Qian Geng

Ge Wang

Affiliations

Soon will be listed here.

Abstract

Gastric cancer is one of the most common malignancies globally; cancer stem cells (CSCs) are regarded as being at the root of tumor progression, and there is thus a need to identify potential drugs to target CSCs. The long non-coding RNA MALAT1 promotes epithelial-mesenchymal transition and angiogenesis in colorectal cancer, but it is unknown whether it affects the stemness of gastric cancer cells. Here, we found that knockdown (KD) of MALAT1 attenuated the stemness of non-adherent gastric cancer cell spheroids, as evidenced by a decrease in primary and secondary spheroid formation capacity and expression of stemness markers. In contrast, overexpression (OE) of MALAT1 enhanced the stemness of adherent gastric cancer cells. Notably, KD of MALAT1 enhanced radiosensitivity and chemosensitivity of gastric cancer cell spheroids. We report that MALAT1 directly binds to sox2 mRNA (which encodes a critical master pluripotency factor), enhances the mRNA stability and increases its expression; KD of sox2 partially reversed the effect of MALAT1 OE on the stemness of gastric cancer cells. Importantly, expression of MALAT1 and sox2 exhibited a positive correlation in clinical samples. Therefore, our results indicate the existence of a novel MALAT1-sox2 axis which promotes the stemness of gastric cancer cells and may be a potential target for gastric cancer.

Citing Articles

The long noncoding RNA ELFN1-AS1 promotes gastric cancer growth and metastasis by interacting with TAOK1 to inhibit the Hippo signaling pathway.

Wang Y, Shen K, Cheng Q, Zhou X, Liu K, Xiao J Cell Death Discov. 2024; 10(1):465.

PMID: 39528458 PMC: 11555383. DOI: 10.1038/s41420-024-02235-5.

P53-associated lncRNAs regulate immune functions and RNA-modifiers in gastric cancer.

Huanjie Z, Bukhari I, Fazhan L, Wen H, Wang J, Wanqing W Heliyon. 2024; 10(15):e35228.

PMID: 39166030 PMC: 11334848. DOI: 10.1016/j.heliyon.2024.e35228.

LINC00998 Modulating M2 Macrophage Activation in Allergic Rhinitis by Stabilizing BOB.1 mRNA.

He Y, Tang Y, Wen S, Dong L, Li F, Deng Y J Inflamm Res. 2024; 17:2309-2326.

PMID: 38638161 PMC: 11026101. DOI: 10.2147/JIR.S444692.

Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.

Xu D, Wang W, Wang D, Ding J, Zhou Y, Zhang W Noncoding RNA Res. 2024; 9(2):388-406.

PMID: 38511067 PMC: 10950606. DOI: 10.1016/j.ncrna.2024.01.015.

The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.

Anbiyaee O, Moalemnia A, Ghaedrahmati F, Khombi Shooshtari M, Khoshnam S, Kempisty B BMC Nephrol. 2023; 24(1):380.

PMID: 38124072 PMC: 10731893. DOI: 10.1186/s12882-023-03438-1.

References

Abdollahpour-Alitappeh M, Razavi-Vakhshourpour S, Abolhassani M . Development of a new anti-CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker. Biotechnol Appl Biochem. 2018; 65(6):841-847. DOI: 10.1002/bab.1681. View

Zhang Y, Pitchiaya S, Cieslik M, Niknafs Y, Tien J, Hosono Y . Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Nat Genet. 2018; 50(6):814-824. PMC: 5980762. DOI: 10.1038/s41588-018-0120-1. View

Song H, Xu Y, Shi L, Xu T, Fan R, Cao M . LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability. Biomed Pharmacother. 2018; 108:338-346. DOI: 10.1016/j.biopha.2018.09.057. View

Chou J, Wang B, Zheng T, Li X, Zheng L, Hu J . MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42. Biochem Biophys Res Commun. 2016; 472(1):262-9. DOI: 10.1016/j.bbrc.2016.02.102. View

White P, Subramanian C, Zhu Q, Zhang H, Zhao H, Gallagher R . Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion. Surgery. 2015; 159(1):142-51. PMC: 4709031. DOI: 10.1016/j.surg.2015.07.050. View

Kim J, Piao H, Kim B, Yao F, Han Z, Wang Y . Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018; 50(12):1705-1715. PMC: 6265076. DOI: 10.1038/s41588-018-0252-3. View

Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang S . The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1. Mol Cancer. 2018; 17(1):69. PMC: 5838949. DOI: 10.1186/s12943-018-0820-2. View

Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S . YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2018; 38(14):2627-2644. PMC: 6484768. DOI: 10.1038/s41388-018-0628-y. View

Zhao L, Han T, Li Y, Sun J, Zhang S, Liu Y . The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4. FASEB J. 2016; 31(3):893-903. DOI: 10.1096/fj.201600994R. View

10.

Duan G, Zhang C, Xu C, Xu C, Zhang L, Zhang Y . Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis. Int J Oncol. 2018; 54(1):17-28. PMC: 6254999. DOI: 10.3892/ijo.2018.4600. View

11.

Gong N, Teng X, Li J, Liang X . Antisense Oligonucleotide-Conjugated Nanostructure-Targeting lncRNA MALAT1 Inhibits Cancer Metastasis. ACS Appl Mater Interfaces. 2018; 11(1):37-42. DOI: 10.1021/acsami.8b18288. View

12.

Li Z, Liu H, Zhong Q, Wu J, Tang Z . LncRNA UCA1 is necessary for TGF-β-induced epithelial-mesenchymal transition and stemness via acting as a ceRNA for Slug in glioma cells. FEBS Open Bio. 2018; 8(11):1855-1865. PMC: 6212641. DOI: 10.1002/2211-5463.12533. View

13.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

14.

Li Z, Wang Y, Hu R, Xu R, Xu W . LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity. Cell Prolif. 2018; 51(6):e12504. PMC: 6528912. DOI: 10.1111/cpr.12504. View

15.

Voutsadakis I . The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer. Breast Cancer (Dove Med Press). 2015; 7:303-19. PMC: 4567227. DOI: 10.2147/BCTT.S71163. View

16.

Hu J, Zhang L, Mei Z, Jiang Y, Yi Y, Liu L . Interaction of E3 Ubiquitin Ligase MARCH7 with Long Noncoding RNA MALAT1 and Autophagy-Related Protein ATG7 Promotes Autophagy and Invasion in Ovarian Cancer. Cell Physiol Biochem. 2018; 47(2):654-666. DOI: 10.1159/000490020. View

17.

Cao S, Wang Y, Li J, Lv M, Niu H, Tian Y . Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function. Am J Cancer Res. 2016; 6(11):2561-2574. PMC: 5126273. View

18.

Guan Z, Cao Y, Li Y, Tong W, Zhuo A . Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer. Cancer Biomark. 2017; 21(3):557-563. DOI: 10.3233/CBM-170431. View

19.

Qin J, Shi H, Xu Y, Zhao F, Wang Q . Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity. Biomed Pharmacother. 2018; 105:758-765. DOI: 10.1016/j.biopha.2018.06.028. View

20.

Jadaliha M, Gholamalamdari O, Tang W, Zhang Y, Petracovici A, Hao Q . A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. PLoS Genet. 2018; 14(11):e1007802. PMC: 6289468. DOI: 10.1371/journal.pgen.1007802. View